International thought leaders in digital health gathered to discuss and collaborate on aging, chronic diseases and care coordination.
Munich, Germany was the location for yesterday’s HealthXL Global Gathering. The event was the fifth such exclusive invite-only event, where 95 international thought leaders gathered to discuss and collaborate on major healthcare challenges.
Aging, chronic diseases and care coordination has been selected by HealthXL and its members as topics to focus on, in hopes of bringing everyone closer in new ways.
For each of these topics, HealthXL brought together a panel of experts to shed light on the problem. After each of the keynotes, two emerging companies presented their solutions to these complex problems.
“We no longer have the capacity to deliver care sufficiently in the traditional acute setting model. Despite years of research and development, the traditional models do not sufficiently address the most serious health issues associated with aging: hypertension, heart failure, type 2 diabetes, Alzheimer’s and Parkinson’s disease. The truth is, management of these chronic diseases needs new thinking and new types of collaboration” said Martin Kelly, CEO and Cofounder of HealthXL.
The audience also heard how HealthXL members IBM Watson Health and ICON are working to automate the cumbersome process of identifying patients to assess feasibility for clinical trials. This is an example of progress towards HealthXL’s Big Data Moonshot: “To Increase Life Expectancy and Improve Quality of Life through Big Data”.
Guests and speakers at the Global Gathering included Sean Hogan VP & General Manager IBM Healthcare; Lisa Suennen Managing Partner, Venture Valkyrie; Julie Murchinson CEO, Health Evolution Summit; Willie Muehlhausen Head of Innovation at ICON plc; Stephen McHale CEO of Explorys, recently acquired by IBM; William Taranto President, Merck Global Health Innovation Fund; Sarah Brice, Consultant Physician and Specialty Lead for Elderly Medicine in Imperial College NHS Trust; Michael Dillhyon, Founder of HealthBank; Jordan Shlain, Founder of HealthLoop and more.
At the event HealthXL also announced the addition of four new members:
- Highmark Health/Allegheny Health Network – the third largest integrated health care delivery and financing system in the United States
- Abbott – a global healthcare company devoted to improving life through the development of products and technologies in nutrition, diagnostics, medical devices and branded generic pharmaceuticals
- Biogen – a global biotechnology company based in Cambridge, Massachusetts
- Imperial College Health Partners – designated Academic Health Science Network (AHSN) for North West London
The four leading healthcare brands are joining the global HealthXL community of 18 members (see detailed list here), to collaborate globally with the other HealthXL partners and some of the most innovative digital health companies.
HealthXL is a global market for health innovations and insights.
Highlights about HealthXL:
- IBM Watson Health and ICON plc announce HealthXL collaboration to revolutionise clinical trial feasibility, patient recruitment and study startup timelines
- PharmaVoice features HealthXL in Top Innovation Companies to Watch for in Healthcare in 2015. More info in the report
- MedTech features Tom Parsons, Cofounder of HealthXL, in 40 Under 40 Healthcare Innovators in 2015. More info in the ranking
- Cleveland Clinic, HealthXL and HealthBeacon collaborate to improve medical adherence. More info in MedCity News article